Making Genetics has developed PAPRAT, a predictive algorithm that employs innovative biomarkers for early stratification of Rheumatoid arthritis (RA) patients to promply implementing the most effective treatment supporting rheumatologists in decision-making.

PREDICTIVE ALGORITHM FOR PRE-RHEUMATOID ARTHRITIS TREATMENT IS AVAILABLE FOR RESEARCH

Our prognosis system will allow rheumatologists to classify pre-RA patients and identify those who will need more aggressive treatment. It is a disruptive precision medicine solution based on advanced analytics and artificial intelligence employing a proprietary algorithm that combines relevant data from patient to predict patient therapeutical needs. It has shown outstanding preclinical results and now we aim to complete its clinical demonstration and obtain CE/FDA approvals. Our flexible and accurate system has been the first focus on RA, and it is easily scalable to other autoimmune diseases in our pipeline.

Contact for more information
blue-1323101_1280.png